Tri Locum Partners LP Cyclacel Pharmaceuticals, Inc. Transaction History

Tri Locum Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.04 - $8.03 $3.16 Million - $4.2 Million	-522,943 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.02 - $11.0 $1.68 Million - $2.31 Million	209,612 Added 66.9%	522,943 $2.76 Million
Q2 2021 Aug 16, 2021	BUY	$7.59 - $10.48 $151,132 - $208,677	19,912 Added 6.79%	313,331 $1.86 Million
Q1 2021 May 17, 2021	BUY	$6.86 - $9.24 $2.01 Million - $2.71 Million	293,419 New	293,419 $2.09 Million

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $7.9M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.